Clinical Trial Update: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial investigates weekly paclitaxel and cisplatin for various breast cancer subtypes, including hormone receptor positive and triple-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer
• Invasive Ductal Breast Cancer
• Mucinous Breast Cancer
• Tubular Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: RenJi Hospital | Conditions: Tubular Breast Cancer, Mucinous Breast Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING